封面
市場調查報告書
商品編碼
1617043

醫院感染控制市場報告:至2030年的趨勢、預測與競爭分析

Hospital-Acquired Infection Control Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫院感染控制趨勢與預測

全球醫院感染控制市場的未來前景廣闊,醫院/ICU、門診手術/診斷中心、療養院/婦產中心市場充滿機會。估計2024年至2030年全球醫院感染控制市場將以1.7%的年複合成長率成長。該市場的主要促進因素是人們對醫院感染的認知和法規的不斷提高以及抗生素抗藥性病原體發生率的上升。

  • Lucintel 預測,防護屏障將在產品和服務類別中成長最快。
  • 在最終用途類別中,醫院和重症監護室預計將成長最快。
  • 依地區分類,北美地區預計成長最快。

醫院感染控制市場的策略性成長機會

醫院感染控制市場在關鍵應用領域提供了多種策略成長機會。這些機會是由技術進步、對有效感染控制解決方案不斷成長的需求以及不斷變化的醫療保健需求所推動的。

  • 兒科感染控制解決方案:兒科患者對專門的感染控制解決方案的需求不斷成長。滿足醫院環境中兒童獨特需求的產品和實踐的發展代表了醫院感染管理市場的重大成長機會。
  • 先進滅菌設備:自動滅菌器、高效過濾器等先進滅菌設備的需求不斷增加。這些技術提高了性能和可靠性,為感染控制領域的製造商和供應商創造了成長機會。
  • 整合數位健康解決方案:將電子健康記錄(EHR)和資料分析等數位健康解決方案整合到感染控制實踐中可以增強監控和合規性。這種整合將帶來更有效和簡化的感染控制管理,並提供成長機會。
  • 開發具有成本效益的解決方案:具有成本效益的感染控制解決方案的市場不斷成長,特別是在發展中地區。透過提供符合感染控制標準的經濟實惠且高效的產品,能夠推動新興市場的成長並滿足資源有限的醫療保健環境的需求。
  • 擴大感染控制服務:將感染控制服務委託給專業提供者的趨勢日益明顯。這為公司提供了一個機會,可以為希望加強感染預防策略的醫療機構提供全面的感染控制服務,包括審核、培訓和管理。

這些成長機會透過推動創新、擴大產品範圍和滿足多樣化的醫療保健需求,塑造 HAI 控制市場的未來。透過致力於開發專業解決方案、具成本效益的技術和綜合服務,支援減少院內感染和提高病人安全的總體目標。

醫院感染控制市場的促進因素與挑戰

醫院感染控制市場受到影響其成長和開發的各種促進因素​​和挑戰的影響。了解這些因素對於駕馭市場和反應不斷變化的需求非常重要。

醫院感染控制市場的促進因素包括:

  • 技術進步:感染控制方面的技術進步,例如自動消毒系統和抗菌塗層,推動市場成長。這些創新將提高感染控制的有效性和效率,並支持減少醫院感染的努力。
  • 提高感染控制意識:人們對感染控制和病人安全重要性的認知不斷提高,推動了對先進感染控制解決方案的需求。醫療保健提供者投資技術和實踐,以加強感染預防和改善患者治療結果。
  • 更嚴格的監管標準:有關感染控制的更嚴格監管標準和指南影響市場成長。醫療機構實施先進的技術和實踐,以遵守這些法規並確保病人安全的高標準。
  • HAI 發生率不斷增加:醫院感染的增加提高對有效感染控制解決方案的需求。醫院尋求創新產品和實踐來應對醫院感染帶來的挑戰並降低感染率。
  • 醫療保健基礎設施的成長:醫療保健基礎設施的擴張和現代化,特別是在新興市場,促進市場成長。改進的設施和先進的感染控制技術的使用支持有效感染控制措施的發展。

醫院感染控制市場面臨的挑戰如下:

  • 先進技術的高成本:與先進感染控制技術相關的高成本可能成為採用的障礙,特別是在資源有限的環境中。解決負擔能力和成本效益對於廣泛採用這些解決方案非常重要。
  • 合規和培訓問題:確保遵守感染控制通訊協定並為醫務人員提供適當的培訓是一項挑戰。遵守最佳實踐的變化可能會影響感染控制的有效性和患者的安全。
  • 監管和安全問題:了解感染控制產品的複雜監管要求並解決安全問題是一項挑戰。確保產品符合監管標準並解決潛在風險對於維持市場可接受性非常重要。

目錄

第1章 執行摘要

第2章 全球醫院感染控制市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球醫院感染控制市場趨勢(2018-2023)與預測(2024-2030)
  • 全球醫院感染控制市場:依產品/服務分類
    • 防護屏障
    • 殺菌
    • 消毒劑
    • 消毒器
    • 內視鏡再生產品
    • 其他
  • 全球醫院感染控制市場:依最終用途分類
    • 醫院及重症監護室
    • 門診手術/診斷中心
    • 療養院/產科中心

第4章 2018-2030年市場趨勢及預測分析,依地區

  • 依地區分類的醫院感染控制市場
  • 北美醫院感染控制市場
  • 歐洲醫院感染控制市場
  • 亞太醫院感染控制市場
  • 其他地區醫院感染控制市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球醫院感染控制市場成長機會(依產品和服務分類)
    • 全球醫院感染控制市場成長機會(依最終用途)
    • 全球醫院感染控制市場成長機會(依地區)
  • 全球醫院感染控制市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球醫院感染控制市場的能力
    • 全球醫院感染控制市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Steris
  • Sotera Health
  • Getinge
  • Advanced Sterilization Products
  • Ecolab
  • 3M
  • Matachana
  • MMM
  • Belimed
  • Reckitt Benckiser
簡介目錄

Hospital-Acquired Infection Control Trends and Forecast

The future of the global hospital-acquired infection control market looks promising with opportunities in the hospital & ICU, ambulatory surgical & diagnostic center, and nursing home & maternity center markets. The global hospital-acquired infection control market is expected to grow with a CAGR of 1.7% from 2024 to 2030. The major drivers for this market are the increasing awareness and regulations regarding hospital-acquired infections and the rising incidence of antibiotic-resistant pathogens.

  • Lucintel forecasts that, within the product & service category, the protective barrier is expected to witness the highest growth.
  • Within the end-use category, hospital & ICU is expected to witness the highest growth.
  • In terms of regions, North America is expected to witness the highest growth.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Hospital-Acquired Infection Control Market

The hospital-acquired infection control market is evolving with several emerging trends driven by technological advancements, increased focus on patient safety, and changing regulatory landscapes.

  • Integration of Real-Time Monitoring Systems: Real-time monitoring systems are becoming increasingly important for tracking infection control compliance and identifying potential risks. These systems use data analytics to monitor hygiene practices and provide alerts, helping healthcare facilities promptly address infection control issues and improve patient safety.
  • Advancements in Antimicrobial Coatings: The development of advanced antimicrobial coatings for surfaces and medical devices is a key trend. These coatings inhibit the growth of pathogens and reduce the risk of HAIs. The use of such coatings enhances the effectiveness of infection control measures in healthcare settings.
  • Increased Adoption of Automated Disinfection Technologies: Automated disinfection technologies, such as UV-C light and robotic systems, are gaining traction. These technologies provide efficient and consistent disinfection, reducing reliance on manual cleaning processes. They contribute to improved infection control by ensuring high levels of cleanliness in hospital environments.
  • Focus on Infection Prevention Training: There is a growing emphasis on comprehensive infection prevention training for healthcare staff. Training programs are being developed to enhance knowledge of infection control protocols and improve adherence to best practices. This trend aims to reduce human errors and enhance overall infection control efforts.
  • Regulatory and Compliance Initiatives: Enhanced regulatory and compliance initiatives are shaping the HAI control market. Stricter guidelines and standards for infection control practices are being enforced by healthcare authorities. Compliance with these regulations is driving the adoption of advanced infection control technologies and practices.

These trends are reshaping the HAI control market by driving innovation, improving infection prevention measures, and enhancing overall patient safety. The integration of new technologies and a stronger focus on training and compliance contribute to more effective infection control strategies in healthcare settings.

Recent Developments in the Hospital-Acquired Infection Control Market

The hospital-acquired infection control market is experiencing several key developments, reflecting advancements in technology, changes in regulations, and evolving healthcare needs.

  • Development of Advanced Disinfection Technologies: New disinfection technologies, such as automated UV-C disinfection systems and electrostatic sprayers, are being introduced. These technologies offer more effective and efficient disinfection processes, improving hospital hygiene and reducing the risk of HAIs.
  • Expansion of Antimicrobial Surface Coatings: The use of antimicrobial coatings on high-touch surfaces and medical equipment is increasing. These coatings help inhibit microbial growth and reduce the transmission of infections, contributing to improved infection control in healthcare settings.
  • Implementation of Real-Time Monitoring Systems: Real-time monitoring systems are being adopted to track and analyze infection control practices. These systems provide valuable data and alerts, helping hospitals address potential issues promptly and ensure compliance with infection control protocols.
  • Enhanced Focus on Infection Prevention Education: There is a growing emphasis on training and education programs for healthcare professionals. These programs aim to improve knowledge and adherence to infection control practices, reducing the incidence of HAIs and promoting a culture of safety.
  • Strengthening Regulatory Compliance: Regulatory bodies are enforcing stricter infection control standards and guidelines. Hospitals are responding by adopting advanced infection control technologies and practices to meet these requirements and ensure patient safety.

These developments are enhancing the effectiveness of infection control measures, driving technological innovation, and improving compliance with regulations. They contribute to a safer healthcare environment by reducing the incidence of hospital-acquired infections and promoting better patient outcomes.

Strategic Growth Opportunities for Hospital-Acquired Infection Control Market

The hospital-acquired infection control market offers several strategic growth opportunities across key applications. These opportunities are driven by technological advancements, increasing demand for effective infection control solutions, and evolving healthcare needs.

  • Pediatric Infection Control Solutions: There is a growing need for specialized infection control solutions tailored for pediatric patients. Developing products and practices that address the unique needs of children in hospital settings presents a significant growth opportunity in the HAI control market.
  • Advanced Sterilization Equipment: The demand for advanced sterilization equipment, such as automated sterilizers and high-efficiency filters, is increasing. These technologies offer improved performance and reliability, presenting growth opportunities for manufacturers and suppliers in the infection control sector.
  • Integration of Digital Health Solutions: Integrating digital health solutions, such as electronic health records (EHR) and data analytics, with infection control practices can enhance monitoring and compliance. This integration offers opportunities for growth by providing more effective and streamlined infection control management.
  • Development of Cost-Effective Solutions: The market for cost-effective infection control solutions is expanding, particularly in developing regions. Offering affordable and efficient products that meet infection control standards can drive growth in emerging markets and address the needs of resource-limited healthcare settings.
  • Expansion of Infection Control Services: There is a growing trend toward outsourcing infection control services to specialized providers. This presents opportunities for companies to offer comprehensive infection control services, including audits, training, and management, to healthcare facilities seeking to enhance their infection prevention strategies.

These growth opportunities are shaping the future of the HAI control market by driving innovation, expanding product offerings, and addressing diverse healthcare needs. Focused development in specialized solutions, cost-effective technologies, and integrated services supports the overall goal of reducing hospital-acquired infections and improving patient safety.

Hospital-Acquired Infection Control Market Driver and Challenges

The hospital-acquired infection control market is influenced by a range of drivers and challenges that impact its growth and development. Understanding these factors is essential for navigating the market and addressing evolving needs.

The factors responsible for driving the hospital-acquired infection control market include:

  • Technological Advancements: Technological advancements in infection control, such as automated disinfection systems and antimicrobial coatings, are driving market growth. These innovations improve the effectiveness and efficiency of infection control measures, supporting efforts to reduce HAIs.
  • Increasing Awareness of Infection Control: Growing awareness about the importance of infection control and patient safety is driving demand for advanced infection control solutions. Healthcare providers are investing in technologies and practices to enhance infection prevention and improve patient outcomes.
  • Stricter Regulatory Standards: Enhanced regulatory standards and guidelines for infection control are influencing market growth. Healthcare facilities are adopting advanced technologies and practices to comply with these regulations and ensure high standards of patient safety.
  • Rising Incidence of HAIs: The increasing incidence of hospital-acquired infections is driving the demand for effective infection control solutions. Hospitals are seeking innovative products and practices to address the challenges posed by HAIs and reduce infection rates.
  • Growth in Healthcare Infrastructure: Expansion and modernization of healthcare infrastructure, particularly in emerging markets, are contributing to market growth. Improved facilities and access to advanced infection control technologies support the development of effective infection control measures.

Challenges in the hospital-acquired infection control market are:

  • High Costs of Advanced Technologies: The high costs associated with advanced infection control technologies can be a barrier to adoption, particularly in resource-limited settings. Addressing affordability and cost-effectiveness is crucial for the broader implementation of these solutions.
  • Compliance and Training Issues: Ensuring compliance with infection control protocols and providing adequate training for healthcare staff can be challenging. Variability in adherence to best practices can impact the effectiveness of infection control measures and patient safety.
  • Regulatory and Safety Concerns: Navigating complex regulatory requirements and addressing safety concerns related to infection control products can pose challenges. Ensuring that products meet regulatory standards and address potential risks is essential for maintaining market acceptance.

The drivers and challenges in the hospital-acquired infection control market shape its growth and development. Technological advancements, increasing awareness, and regulatory standards drive market expansion, while high costs, compliance issues, and regulatory concerns pose challenges. Addressing these factors is crucial for advancing infection control practices and improving patient safety in healthcare settings.

List of Hospital-Acquired Infection Control Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies hospital-acquired infection control companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hospital-acquired infection control companies profiled in this report include-

  • Steris
  • Sotera Health
  • Getinge
  • Advanced Sterilization Products
  • Ecolab
  • 3M
  • Matachana
  • MMM
  • Belimed
  • Reckitt Benckiser

Hospital-Acquired Infection Control by Segment

The study includes a forecast for the global hospital-acquired infection control by product & service, end use, and region.

Hospital-Acquired Infection Control Market by Product & Service [Analysis by Value from 2018 to 2030]:

  • Protective Barrier
  • Sterilization
  • Disinfectant
  • Disinfector
  • Endoscope Reprocessing Product
  • Others

Hospital-Acquired Infection Control Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospital & ICU
  • Ambulatory Surgical & Diagnostic Center
  • Nursing Home & Maternity Center

Hospital-Acquired Infection Control Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Hospital-Acquired Infection Control Market

The hospital-acquired infection (HAI) control market is advancing rapidly as healthcare systems worldwide focus on reducing infection rates and improving patient safety. Innovations in infection control technologies, increased awareness, and regulatory pressures are driving these developments. Key markets, including the United States, China, Germany, India, and Japan, are witnessing significant changes in infection control practices and technologies aimed at combating HAIs.

  • United States: In the U.S., there is a notable shift toward advanced infection control technologies, including real-time monitoring systems and enhanced sterilization methods. The implementation of stringent infection prevention protocols and increased use of antimicrobial surfaces are key trends. Regulatory mandates and heightened awareness around HAIs are further driving the adoption of comprehensive infection control strategies across healthcare facilities.
  • China: China is experiencing growth in the HAI control market due to increased investment in healthcare infrastructure and infection prevention technologies. The country is focusing on improving hospital hygiene practices and implementing more rigorous infection control measures. Government initiatives and growing public health awareness are contributing to the expansion of advanced infection control solutions in hospitals.
  • Germany: Germany is seeing advancements in infection control practices with the adoption of automated disinfection systems and improved personal protective equipment (PPE). The focus is on integrating new technologies with traditional infection control methods to enhance efficacy. Additionally, Germany is emphasizing the importance of staff training and adherence to infection prevention protocols to reduce HAIs.
  • India: In India, the HAI control market is expanding as hospitals adopt new infection control technologies and practices. The emphasis is on cost-effective solutions and improving hospital hygiene standards. Government initiatives aimed at reducing infection rates and increasing awareness about HAIs are driving growth in the infection control market.
  • Japan: Japan is witnessing advancements in infection control technologies, including the use of advanced sterilization techniques and antimicrobial coatings. There is a strong focus on integrating technology with traditional infection control measures to enhance overall effectiveness. Japan's emphasis on patient safety and regulatory compliance is contributing to the growth of the HAI control market.

Features of the Global Hospital-Acquired Infection Control Market

Market Size Estimates: Hospital-acquired infection control market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hospital-acquired infection control market size by product & service, end use, and region in terms of value ($B).

Regional Analysis: Hospital-acquired infection control market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, end uses, and regions for the hospital-acquired infection control market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hospital-acquired infection control market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hospital-acquired infection control market by product & service (protective barrier, sterilization, disinfectant, disinfector, endoscope reprocessing product, and others), end use (hospital & ICU, ambulatory surgical & diagnostic center, and nursing home & maternity center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hospital-Acquired Infection Control Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hospital-Acquired Infection Control Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hospital-Acquired Infection Control Market by Product & Service
    • 3.3.1: Protective Barrier
    • 3.3.2: Sterilization
    • 3.3.3: Disinfectant
    • 3.3.4: Disinfector
    • 3.3.5: Endoscope Reprocessing Product
    • 3.3.6: Others
  • 3.4: Global Hospital-Acquired Infection Control Market by End Use
    • 3.4.1: Hospital & ICU
    • 3.4.2: Ambulatory Surgical & Diagnostic Center
    • 3.4.3: Nursing Home & Maternity Center

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hospital-Acquired Infection Control Market by Region
  • 4.2: North American Hospital-Acquired Infection Control Market
    • 4.2.1: North American Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.2.2: North American Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center
  • 4.3: European Hospital-Acquired Infection Control Market
    • 4.3.1: European Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.3.2: European Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center
  • 4.4: APAC Hospital-Acquired Infection Control Market
    • 4.4.1: APAC Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.4.2: APAC Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center
  • 4.5: ROW Hospital-Acquired Infection Control Market
    • 4.5.1: ROW Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.5.2: ROW Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hospital-Acquired Infection Control Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Hospital-Acquired Infection Control Market by End Use
    • 6.1.3: Growth Opportunities for the Global Hospital-Acquired Infection Control Market by Region
  • 6.2: Emerging Trends in the Global Hospital-Acquired Infection Control Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hospital-Acquired Infection Control Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hospital-Acquired Infection Control Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Steris
  • 7.2: Sotera Health
  • 7.3: Getinge
  • 7.4: Advanced Sterilization Products
  • 7.5: Ecolab
  • 7.6: 3M
  • 7.7: Matachana
  • 7.8: MMM
  • 7.9: Belimed
  • 7.10: Reckitt Benckiser